Global Passive Immunizing Drugs against Rabies Market Growth 2024-2030

Global Passive Immunizing Drugs against Rabies Market Growth 2024-2030

Passive immunization against rabies refers to the administration of pre-formed antibodies,to provide immediate but temporary protection against the rabies virus.This approach delivers antibodies directly to neutralize the virus and prevent it from spreading,offering short-term immunity while the recipient's own immune system is stimulated by the rabies vaccine to develop a long-lasting immune response,which is especially critical in the early stages following potential exposure to rabies.

The global Passive Immunizing Drugs against Rabies market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Passive Immunizing Drugs against Rabies Industry Forecast” looks at past sales and reviews total world Passive Immunizing Drugs against Rabies sales in 2023, providing a comprehensive analysis by region and market sector of projected Passive Immunizing Drugs against Rabies sales for 2024 through 2030. With Passive Immunizing Drugs against Rabies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Passive Immunizing Drugs against Rabies industry.

This Insight Report provides a comprehensive analysis of the global Passive Immunizing Drugs against Rabies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Passive Immunizing Drugs against Rabies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Passive Immunizing Drugs against Rabies market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Passive Immunizing Drugs against Rabies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Passive Immunizing Drugs against Rabies.

United States market for Passive Immunizing Drugs against Rabies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Passive Immunizing Drugs against Rabies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Passive Immunizing Drugs against Rabies is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Passive Immunizing Drugs against Rabies players cover Kedrion Biopharma, Grifols, Sanofi Pasteur, Kamada, Zydus Lifesciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Passive Immunizing Drugs against Rabies market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Rabies Immunoglobulin
Anti-rabies Serum
Rabies Virus Monoclonal Antibody

Segmentation by Application:
Category II Exposure
Category III Exposure

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Kedrion Biopharma
Grifols
Sanofi Pasteur
Kamada
Zydus Lifesciences
Serum Institute of India
Sichuan Yuanda Shuyang Pharmaceutical
Sinopharm Group
Haffkine Bio-Pharmaceutical
Bharat Biotech
Sharon Bio-Medicine
Wuhan Institute of Biological Products
North China Pharmaceutical
Xingmeng Biopharmaceuticals (Suzhou)
Hualan Biological Engineering
Shanxi Kangbao Biological Product

Key Questions Addressed in this Report

What is the 10-year outlook for the global Passive Immunizing Drugs against Rabies market?

What factors are driving Passive Immunizing Drugs against Rabies market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Passive Immunizing Drugs against Rabies market opportunities vary by end market size?

How does Passive Immunizing Drugs against Rabies break out by Type, by Application?



Please note: The report will take approximately 2 business days to prepare and deliver. Show more